Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section listing North Carolina (Duke University Medical Center, Durham) and South Carolina (Columbia and Lexington Medical Center) study sites, replacing the prior separate state location headings; removed the HHS Vulnerability Disclosure link in the footer as part of Revision: v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:56:50.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.2.0 to v3.3.2, indicating a minor update to the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:28:23.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removal of the government funding notice banner at the top of the ClinicalTrials.gov study page.
    Difference
    0.4%
    Check dated 2025-11-18T07:11:27.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No substantive changes to the study details or eligibility criteria are evident between the two screenshots; any differences seem to be formatting, spacing, or UI elements rather than content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:13:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:50:00.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:09:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.